logo

TNXP’s Market Fluctuations: Is Now the Right Time to Invest?

VIPS stock

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 16.16% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -27.31%. Over the past 30 days, the price of TNXP has leaped by -37.36%. And in the last five days, it has surged by 63.02%.

Tonix Pharmaceuticals Holding Corp’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $12.48 on 02/20/24, with the lowest value being $0.12 on 10/03/24.

52-week price history of TNXP Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Tonix Pharmaceuticals Holding Corp’s current trading price is -96.93% away from its 52-week high, while its distance from the 52-week low is 224.66%. The stock’s price range over this timeframe has been between $0.12 and $12.48. The shares of the Healthcare sector company recorded a trading volume of approximately 180.29 million for the day, which was comparatively higher than the average daily volume of 113.32 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly rise of 112.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 71.60M and boasts a workforce of 103 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2073, with a change in price of +0.1274. Similarly, Tonix Pharmaceuticals Holding Corp recorded 82,533,914 in trading volume during the last 100 days, posting a change of +49.82%.

TNXP’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TNXP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.08.

TNXP Stock Stochastic Average

Tonix Pharmaceuticals Holding Corp’s raw stochastic average for the past 50 days is currently at 21.87%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 76.65%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 44.49% and 24.95%, respectively.

Most Popular